Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
Copyright policy )Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer
Colorectal tumors are continuously exposed to an inflammatory environment, which together with mitogenic signals sustain several cancer hallmarks. Nuclear factor-kappa B (NFκB) is a major regulator of inflammation and variation in NFκB-associated genes could potentially be used as biomarkers to identify patients with increased risk of colorectal cancer (CRC) development, and/or a rapidly progressing disease. In this study, 348 CRC cases and 806 randomly selected healthy individuals from southeastern Sweden were examined with regard to seven polymorphisms in NFκB pathway-associated genes. Log-rank-tests and Cox proportional hazard regression analysis examined the association between the polymorphisms and CRC-specific survival, whereas chi-square tests and logistic regression analysis were used to test for associations between the polymorphisms and CRC susceptibility. Gene expression and loss of heterozygosity analyses of TNFAIP3 were carried out in a subset of tumors to assess its role as a tumor suppressor in CRC. Heterozygous and polymorphic TNFAIP3 (rs6920220), heterozygous NLRP3 (Q705K) and polymorphic NFκB -94 ATTG ins/del genotypes were found to be associated with poorer survival in patients diagnosed with invasive CRC (aHR = 5.2, 95% CI: 2.5-10.9, P < 0.001). TNFAIP3 mRNA levels were significantly decreased in tumors compared with adjacent non-neoplastic mucosa (P < 0.0001) and loss of heterozygosity of 6q23.3 (TNFAIP3) was detected in 17% of cases, whereas only 2.5% of the investigated specimens displayed TNFAIP3 gene mutations. We propose that TNFAIP3 (rs6920220), NLRP3 (Q705K) and NFκB -94 ATTG ins/del polymorphisms are associated with poor survival in patients with advanced CRC and may be used as prognostic markers. Experimental results indicate that TNFAIP3 may act as a tumor suppressor in CRC.
- Linköping University Sweden
- Örebro University Sweden
Adult, Male, Medicin och hälsovetenskap, Inflammasomes, Loss of Heterozygosity, Medical and Health Sciences, NLR Family, Pyrin Domain-Containing 3 Protein, Humans, Genetic Predisposition to Disease, Aged, Neoplasm Staging, Aged, 80 and over, Intracellular Signaling Peptides and Proteins, NF-kappa B, Middle Aged, DNA-Binding Proteins, Case-Control Studies, Female, Carrier Proteins, Colorectal Neoplasms, Gene Deletion, Follow-Up Studies
Adult, Male, Medicin och hälsovetenskap, Inflammasomes, Loss of Heterozygosity, Medical and Health Sciences, NLR Family, Pyrin Domain-Containing 3 Protein, Humans, Genetic Predisposition to Disease, Aged, Neoplasm Staging, Aged, 80 and over, Intracellular Signaling Peptides and Proteins, NF-kappa B, Middle Aged, DNA-Binding Proteins, Case-Control Studies, Female, Carrier Proteins, Colorectal Neoplasms, Gene Deletion, Follow-Up Studies
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).132 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!